Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Ciprofloxacin | Chloro ciprofloxacin | VL204008 | View CAS 93106-58-2 |
Ciprofloxacin | Ciprofloxacin EP Impurity A | VL204004 | View CAS 86393-33-1 |
Ciprofloxacin | Ciprofloxacin EP Impurity B | VL204005 | View |
Ciprofloxacin | Ciprofloxacin EP Impurity C | VL204002 | View CAS 528851-31-2 |
Ciprofloxacin | Ciprofloxacin EP Impurity C (Free Base) | VE007082 | View CAS 103222-12-4 |
Ciprofloxacin | Ciprofloxacin EP Impurity D | VL204006 | View CAS 526204-10-4 |
Ciprofloxacin | Ciprofloxacin EP Impurity D (Free Base) | VE007083 | View CAS 133210-96-5 |
Ciprofloxacin | Ciprofloxacin EP Impurity E | VL204003 | View CAS 105394-83-0 |
Ciprofloxacin | Ciprofloxacin EP Impurity E (HCl Salt) | VE0010231 | View |
Ciprofloxacin | Ciprofloxacin EP Impurity F | VL204001 | View CAS 226903-07-7 |
Ciprofloxacin | Ciprofloxacin N-Formyl Impurity | VL204011 | View CAS 93594-39-9 |
Ciprofloxacin | Desfluoro Ciprofloxacin (Free Base) | VE007084 | View CAS 93107-11-0 |
Ciprofloxacin | N-ethoxy Carbonyl Ciprofloxacin Impurity | VL204010 | View CAS 93594-29-7 |
Ciprofloxacin Related Compound
Ciprofloxacin is used to treat or prevent certain bacterial diseases, including pneumonia, gonorrhea (a sexually transmitted disease), typhoid fever (a dangerous infection frequent in poor countries), and infectious diarrhea.
References
- “Ciprofloxacin (Oral Route) Description and Brand Names – Mayo Clinic.” Mayoclinic.org, 2023, www.mayoclinic.org/drugs-supplements/ciprofloxacin-oral route/description/drg-20072288. Accessed 1 Feb. 2023.
- “Ciprofloxacin (Oral Route) Side Effects – Mayo Clinic.” Mayoclinic.org, 2023, www.mayoclinic.org/drugs-supplements/ciprofloxacin-oral-route/side-effects/drg 20072288?p=1. Accessed 1 Feb. 2023.
- “Enforcement Reports.” Www.accessdata.fda.gov, www.accessdata.fda.gov/drugsatfda_docs/label/2013/019537s082.
FAQ’s
What therapeutic category does ciprofloxacin fall under?
Ciprofloxacin belongs to the quinolone antibiotic group of medicines.
Does ciprofloxacin treat UTI?
Ciprofloxacin extended-release tablets are specifically prescribed for the treatment of urinary tract infections, such as acute uncomplicated pyelonephritis.
What is the mechanism of action of ciprofloxacin?
Ciprofloxacin’s bactericidal activity is caused by suppression of the enzymes topoisomerase
II (DNA gyrase) and topoisomerase IV (both Type II topoisomerases), which are necessary
for bacterial DNA replication, transcription, repair, and recombination.